Procurement Summary
Country: Brazil
Summary: Process for Potential Purchase of Medicines Belonging to Group 09.A.09.A (Digestives Including Enzymes), Group (09.C.09.D Angiotensin Ii Antagonist, Association) and Group 09.D.05.B (Antip...
Deadline: 08 Apr 2026
Posting Date: 26 Mar 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 138517902
Document Ref. No.: 90089/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Process for potential purchase of medicines belonging to Group 09.A.09.A (DIGESTIVES INCLUDING ENZYMES), Group (09.C.09.D ANGIOTENSIN II ANTAGONIST, ASSOCIATION) and Group 09.D.05.B (ANTIPSORIATICS FOR SYSTEMIC USE), with the aim of maintaining regular supply to the State Department of Health of the Federal District - SES/DF, in an uninterrupted manner, as well as guaranteeing assistance to SUS/DF users, in a price registration system, according to specifications and quantity UASG Code: 926119 Notice from: 03/26/2026 from 08:00 to 12:00 and from 14:00 to 17:00 Proposal Delivery: from 03/26/2026 at 08:00 PANCREATIC ENZYMES, ACTIVE PRINCIPLE PANCREATIN (AMYLASE + LIPASE + PROTEASE), CONCENTRATION 25, 000 IU Quantity: 1074105 PANCREATIC ENZYMES, ACTIVE INGREDIENT PANCREATIN (AMYLASE + LIPASE + PROTEASE), CONCENTRATION 25, 000 IU Quantity: 358035 PANCREATIC ENZYMES, ACTIVE PRINCIPLE PANCREATIN (AMYLASE + LIPASE + PROTEASE), DOSAGE 10, 000 IU Quantity: 148440 VALSARTANA, COMPOSITION ASSOCIATED WITH SACUBITRIL, CONCENTRATION 103 MG + 97 MG Quantity: 405300 VALSARTANA, COMPOSITION ASSOCIATED WITH SACUBITRIL, CONCENTRATION 26 MG + 24 MG Quantity: 269040 ACITRETIN, DOSAGE 25 MG Quantity: 36582
Documents
Tender Notice